Last Price
16.03
Today's Change
-0.06 (0.37%)
Day's Change
15.93 - 16.55
Trading Volume
1,349,960
Overview
Market Cap
1 Billion
Shares Outstanding
119 Million
Avg Volume
1,591,800
Avg Price (50 Days)
14.78
Avg Price (200 Days)
14.25
PE Ratio
-41.10
EPS
-0.39
Earnings Announcement
06-Nov-2024
Previous Close
16.09
Open
16.20
Day's Range
15.93 - 16.54
Year Range
9.83 - 17.95
Trading Volume
1,185,366
Price Change Highlight
1 Day Change
-0.37%
5 Day Change
11.47%
1 Month Change
4.43%
3 Month Change
-0.19%
6 Month Change
17.78%
Ytd Change
7.58%
1 Year Change
21.72%
3 Year Change
-70.58%
5 Year Change
-70.58%
10 Year Change
-70.58%
Max Change
-70.58%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Medical Instruments & Supplies
Description:
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Intel Gets Multibillion-dollar Apollo Offer as Qualcomm Circles
2
CEO Morning Brief
3
CEO Morning Brief
Citigroup's China Expansion Held Up by US Regulators — Bloomberg
4
CEO Morning Brief
US Worries Deepen as Adversaries Team Up to Challenge Dominance
5
CEO Morning Brief
Brazil Sugar Losses Make Thai and Indian Supply More Important
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
